Module 3: Zanubrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, Anthony Mato, MD, MSCE
7:59
5Live
Module 3: Zanubrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, Anthony Mato, MD, MSCE
5Live Similar Videos
Similar Videos
-
Module 1: Ibrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs_MD_Anthony Mato, MD, MSCE
9:28
-
Module 1_Introduction and Rationale for Targeting BCMA on MM Cells
10:45
-
IUCLS 2023 Saturday Afternoon General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS
3:34